ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

CARA Cara Therapeutics Inc

0,6843
-0,0157 (-2,24%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cara Therapeutics Inc CARA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0157 -2,24% 0,6843 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,69 0,68 0,7264 0,6843 0,70
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.4.202413:00GLOBECara Therapeutics to Present at the 23rd Annual Needham..
07.3.202413:00GLOBECara Therapeutics to Host Notalgia Paresthetica (NP) Virtual..
06.3.202422:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
04.3.202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:10EDGAR2Form 8-K - Current report
04.3.202422:01GLOBECara Therapeutics Announces Fourth Quarter and Full Year..
14.2.202400:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:01GLOBECara Therapeutics to Announce Fourth Quarter and Full Year..
05.2.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:59EDGAR2Form 8-K - Current report
29.1.202421:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22.1.202422:19EDGAR2Form 8-K - Current report
22.1.202413:00GLOBECara Therapeutics Prioritizes Late-Stage Notalgia..
18.12.202313:10EDGAR2Form 8-K - Current report
18.12.202313:00GLOBECara Therapeutics Announces Outcome from Dose-Finding Part A..
13.11.202322:28EDGAR2Form 8-K - Current report
13.11.202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:11EDGAR2Form 8-K - Current report
13.11.202322:01GLOBECara Therapeutics Reports Third Quarter 2023 Financial..
03.11.202321:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202312:10EDGAR2Form 8-K - Current report
02.11.202312:00GLOBECara Therapeutics Announces up to $40.0 Million Non-Dilutive..
23.10.202313:00GLOBECara Therapeutics to Announce Third Quarter 2023 Financial..
25.9.202313:00GLOBECara Therapeutics Announces Approval of KORSUVA® IV..
05.9.202313:00GLOBECara Therapeutics to Present at the H.C. Wainwright 25th..
07.8.202322:24EDGAR2Form 8-K - Current report
07.8.202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:10EDGAR2Form 8-K - Current report
07.8.202322:01GLOBECara Therapeutics Reports Second Quarter 2023 Financial..
04.8.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.8.202323:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202313:06EDGAR2Form 8-K - Current report
03.8.202313:00GLOBECara Therapeutics Appoints Helen M. Boudreau to Board of..
02.8.202313:00GLOBECara Therapeutics to Present at the Canaccord Genuity 43rd..
25.7.202322:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24.7.202313:00GLOBECara Therapeutics to Announce Second Quarter 2023 Financial..
03.6.202300:46PRNUSPalo Alto Networks Set to S&P 500; Others to Join S&P MidCap..
01.6.202313:00GLOBECara Therapeutics to Present at the Jefferies Healthcare..
18.5.202308:00GLOBEKapruvia® (difelikefalin) recommended by England’s NICE for..
15.5.202322:01GLOBECara Therapeutics Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock